ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,189Medicare Part D Prescriptions Filled, Including Refills

Rank: 73 out of 324

$523K Total Retail Price of All Prescriptions

Rank: 96 out of 324

405 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 405 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 405 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 10,198 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
AMLODIPINE BESYLATE 593 571 1 4
SIMVASTATIN 547 508 2 1
LEVOTHYROXINE SODIUM 480 456 3 2
FUROSEMIDE 392 362 4 7
METOPROLOL SUCCINATE 298 292 5 17
METFORMIN HCL 266 227 6 9
LISINOPRIL 250 226 7 3
POTASSIUM CHLORIDE 245 223 8 8
HYDROCHLOROTHIAZIDE 242 224 9 11
ALENDRONATE SODIUM 219 188 10 24
ATENOLOL 212 200 11 18
ATORVASTATIN CALCIUM 209 204 12 12
OMEPRAZOLE 190 174 13 6
METOPROLOL TARTRATE 185 158 14 14
HYDROCODONE-ACETAMINOPHEN 178 144 S3 15 5
ENALAPRIL MALEATE 178 161 15 57
WARFARIN SODIUM 177 174 17 10
CITALOPRAM HBR 154 148 18 16
GABAPENTIN 149 134 19 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 146 139 20 35
LOSARTAN-HYDROCHLOROTHIAZIDE 117 117 21 44
TRAMADOL HCL 111 110 22 19
NEXIUM 106 85 23 33
DONEPEZIL HCL 101 101 24 25
LOSARTAN POTASSIUM 95 95 25 15
PAROXETINE HCL 89 77 26 72
SERTRALINE HCL 88 54 27 23
CLOPIDOGREL 86 77 28 38
CARVEDILOL 81 71 29 22
TAMSULOSIN HCL 78 78 30 26
ALLOPURINOL 78 78 30 27
DIOVAN 76 76 32 56
RANITIDINE HCL 75 60 33 58
AMITRIPTYLINE HCL 73 49 R 34 66
LIPITOR 70 62 35 109
SPIRIVA 69 59 36 70
PLAVIX 68 59 37 63
ESCITALOPRAM OXALATE 64 64 38 54
ADVAIR DISKUS 63 54 39 61
ACTOS 63 57 39 131
TRICOR 62 50 41 126
NIFEDIPINE ER 61 57 42 135
GLIMEPIRIDE 61 61 42 37
POLYETHYLENE GLYCOL 3350 59 47 44 49
LANTUS 57 39 45 39
NOVOLOG 56 49 46 60
CARBIDOPA-LEVODOPA 55 55 47 80
LEVETIRACETAM 54 28 48 120
KLOR-CON M20 54 50 48 52
OXYCODONE-ACETAMINOPHEN 53 52 S2 50 97
FINASTERIDE 53 53 50 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 31, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.